Side-by-side financials for CLLS and BIIB. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLLS | BIIB |
|---|---|---|
| Market cap | - | $29.52 B |
| US-listed rank | - | #471 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | - | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.8 |
| SEC filings | 517 | 2,690 |
Full pages: Cellectis S.A. and BIOGEN INC., or browse the full rankings.